Acceptance rate 46%
Time to first decision 5 days*
Time to decision with review 50 days*

*approximate number of days


ACTA Pharmaceutica Sciencia 2023 , Vol 61 , Num 4
Abstract PDF Similar Articles Mail to Author
DBeQ-mediated pharmacological modulation of the retrotranslocation step of ERAD may exhibit a potent therapeutic approach against colorectal cancer
Yalcin ERZURUMLU 1 Hatice Kubra DOGAN 2
1 Department of Biochemistry, Faculty of Pharmacy, Suleyman Demirel University, 32260, Isparta, Türkiye
2 Department of Bioengineering, Institute of Science, Suleyman Demirel University, 32260, Isparta, Türkiye
DOI : 10.23893/1307-2080.APS6125 Keywords :

Istanbul Medipol University